Rephonic
Artwork for Lung Cancer Considered

Lung Cancer Considered

IASLC
Lung Cancer
Immunotherapy
Biomarker Testing
Early-Stage Non-Small Cell Lung Cancer
EGFR Mutation
Non-Smokers
Non-Small Cell Lung Cancer
Chemoimmunotherapy
Low-Dose CT Scans
EGFR Mutant Non-Small Cell Lung Cancer
Chemotherapy
National Lung Screening Trial
Demographics Of Lung Cancer
Targeted Therapy
Molecular Therapy
Genetic Testing
Central Nervous System Metastases
Neoadjuvant Therapy
Adjuvant Therapy
ASCO 2024

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 co... more

PublishesTwice weeklyEpisodes370Founded7 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Lung Cancer Considered

Latest Episodes

This episode of Lung Cancer Considered, hosted by Dr. Narjust Florez, examines the challenges of delivering lung cancer care in areas affected by war and displacement with guests Dr. Julie Gralow and Dr. Rafal Dziadziuszko. The discussion addresses d... more

As part of IASLC’s ongoing series of Lung Cancer Considered podcast episodes in world languages, Dr. Ece Cali moderates a discussion in Turkish with Dr. Irfan Çiçin and Dr. Fulden Yumuk. The episode is part of our Virtual Tumor Board series and focus... more

This episode reviews the IASLC 2025 Hot Topic in Basic and Translational Science Conference, which focused on unraveling precancer and early-stage lung cancer, a theme that really captures where the field is heading. Instead of reacting to advanced d... more

As part of IASLC’s Lung Cancer Considered World Language Series, guest host Dr. Maria Cecilia Mathias leads a discussion in Portuguese about the junior faculty perspective with Dr. Maria Thereza Starling and Dr. Paula Duarte.

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

OncLive® On Air
OncLive® On AirOncLive® On Air
The Journal.
The Journal.The Wall Street Journal & Spotify Studios
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Dr. Triparna Sen
Professor of Internal Medicine at The Ohio State University and Director of the Lung Cancer Preclinical Therapeutics Platform.
The Ohio State University
Episode: Lung Cancer Considered: IASLC Hot Topic in Basic & Translational Science Meeting Highlights
Dr. Aaron Tan
Physician scientist focusing on early detection and translational biology in lung cancer.
National Cancer Centre Singapore
Episode: Lung Cancer Considered: IASLC Hot Topic in Basic & Translational Science Meeting Highlights
Paula Duarte
Thoracic surgeon
University of São Paulo (USP)
Episode: Lung Cancer Considered in Portuguese: Junior Faculty Perspective
Maria Thereza Starling
Radiation oncologist, specializing in thoracic oncology
Hospital Madre Teresa
Episode: Lung Cancer Considered in Portuguese: Junior Faculty Perspective
Dr. Gerina Reiter
A thoracic pulmonologist and thoracic oncologist at the Netherlands Cancer Institute, principal investigator in several clinical trials.
Netherlands Cancer Institute
Episode: FDA Approval: Zongertinib for HER2 Mutant NSCLC
Dr. Ivi Dagojjak
A thoracic medical oncologist from Mass General Hospital and associate professor of medicine at Harvard Medical School.
Mass General Hospital
Episode: FDA Approval: Zongertinib for HER2 Mutant NSCLC
Bryant Lin
Clinical Professor of Medicine at Stanford University, primary care physician, educator, and researcher with stage 4 EGFR mutant lung cancer.
Stanford University
Episode: Dr. Bryant Lin Teaching My Cancer
Dr. Christine Loevely
Associate Professor of Medicine at the Vanderbilt Ingram Cancer Center
Vanderbilt Ingram Cancer Center
Episode: AACR 2025 Highlights
Dr. Aldea
Visiting scientist at the Nafarva Cancer Institute, creator of the largest registry for RET-positive non-small cell lung cancer
Gustav Roussi
Episode: What You Should Know About RET-Positive NSCLC: Live from TexasLung25

Hosts

Dr. Narjust Florez
Co-Director of the Young Lung Cancer Program and Associate Director of the Cancer Care Equity Program. Expert in lung cancer treatment and research, emphasizing on Young Adult Lung Cancer.
Dr. Stephen Liu
Host and oncologist specializing in lung cancer considered to be a leading voice in thoracic oncology. Has significant contributions to lung cancer research and advocacy.

Reviews

4.6 out of 5 stars from 42 ratings
  • Episode on Immunotherapy

    Really enjoyed the conversation between these oncologist. They seem to be great doctors who really care for their patients are working for the best solutions they know of.

    It was also interesting to see their blind spots. The great thing about immunotherapy is slowly opening the door between integrative oncology and traditional oncology. These guys don’t get into it but they are asking the right questions.

    1) What can be combined with immunotherapy?

    2) What can be done to prevent side effec... more

    Apple Podcasts
    5
    TBobo
    United States4 years ago
  • Fantastic for doctors, nurses, patients

    Great conversations on all things lung cancer.

    Apple Podcasts
    5
    DrFLC
    United States5 years ago
  • :)

    great info!

    Apple Podcasts
    5
    yeoohaz
    United States5 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate the in-depth analysis of lung cancer topics, particularly valuing the high level of expertise brought by hosts and guests.
Overall feedback highlights the series as a vital resource for staying informed about lung cancer research advancements.
Many emphasize the importance of patient-focused discussions and the relevance of the shared experiences of both medical professionals and patients.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#207
Israel/Science
Apple Podcasts
#219
South Korea/Science
Apple Podcasts
#243
Hong Kong/Science

Talking Points

Recent interactions between the hosts and their guests.

Lung Cancer Considered: IASLC Hot Topic in Basic & Translational Science Meeting Highlights
Q: Aaron, what are we learning about the effects of immunity or immune system in pre-cancer?
The immune system may cause rewiring of lung epithelial cells to become permissive to disease development, influenced by factors like air pollution and inflammatory microenvironments.
Lung Cancer Considered: IASLC Hot Topic in Basic & Translational Science Meeting Highlights
Q: Triparna, I want to start with you. Why has pre-cancer or early-stage disease become such a critical focus now?
Lung cancer research has shifted from late-stage metastatic disease to early detection due to advancements in understanding how lung cancer develops, recognizing the dynamic nature of pre-cancer lesions.
FDA Approval: Zongertinib for HER2 Mutant NSCLC
Q: Where will we fit this agent if it gets approved when it comes to treatment sequencing for HER2?
If approved, Zongertinib would initially serve as a second-line treatment after first-line options including platinum-based chemotherapy.
FDA Approval: Zongertinib for HER2 Mutant NSCLC
Q: What therapies are we using for first and second line therapy?
Currently, the standard of care includes platinum-based chemotherapy with or without immunotherapy for first line, and Trastuzumab diruxetocan as a second-line targeted therapy.
Dr. Bryant Lin Teaching My Cancer
Q: What advice do you have for physicians who find themselves in similar situations?
Avoid fixating on survival statistics because they won't change what you do; instead, focus on living day-to-day.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Considered

What is Lung Cancer Considered about and what kind of topics does it cover?

A focused and informative series that revolves around advancements and insights in lung cancer research and treatment. Episodes feature discussions on various novel therapies, clinical trials, and expert insights surrounding lung cancer topics including immunotherapy and targeted therapies. This podcast also addresses significant themes such as patient experiences, effective communication in healthcare, and the influence of multidisciplinary approaches to lung cancer management. Its unique perspective is derived from the inclusion of both oncologists and patients, shedding light on the complexities of lung cancer treatment and the crucial importance of tailored patient care strategies.

The participation of leading experts and oncologists f... more

Where can I find podcast stats for Lung Cancer Considered?

Rephonic provides a wide range of podcast stats for Lung Cancer Considered. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Considered and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Considered get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Considered, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Considered?

Rephonic provides comprehensive predictive audience data for Lung Cancer Considered, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Considered have?

To see how many followers or subscribers Lung Cancer Considered has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Considered?

These podcasts share a similar audience with Lung Cancer Considered:

1. Oncology Brothers: Practice-Changing Cancer Discussions
2. OncLive® On Air
3. The Journal.
4. Up First from NPR
5. ASCO Daily News

How many episodes of Lung Cancer Considered are there?

Lung Cancer Considered launched 7 years ago and published 370 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Considered?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Considered?

Rephonic pulls ratings and reviews for Lung Cancer Considered from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Considered?

Rephonic provides full transcripts for episodes of Lung Cancer Considered. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Considered?

Recent guests on Lung Cancer Considered include:

1. Dr. Triparna Sen
2. Dr. Aaron Tan
3. Paula Duarte
4. Maria Thereza Starling
5. Dr. Gerina Reiter
6. Dr. Ivi Dagojjak
7. Bryant Lin
8. Dr. Christine Loevely

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days